Drug Shortage Report for CONSTELLA
Report ID | 162251 |
Drug Identification Number | 02469510 |
Brand name | CONSTELLA |
Common or Proper name | linaclotide capsules |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | LINACLOTIDE |
Strength(s) | 72MCG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 30s |
ATC code | A06AX |
ATC description | DRUGS FOR CONSTIPATION |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-06-09 |
Actual start date | |
Estimated end date | 2022-07-08 |
Actual end date | 2022-07-08 |
Shortage status | Resolved |
Updated date | 2022-07-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-07-10 | French | Compare |
v4 | 2022-07-10 | English | Compare |
v3 | 2022-06-10 | English | Compare |
v2 | 2022-06-09 | French | Compare |
v1 | 2022-06-09 | English | Compare |
Showing 1 to 5 of 5